Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNM1 | Q05193 | 4/20 | 0.39 |
| ▸ | CA1 | P00915 | 8/20 | 0.36 |
| ▸ | CA2 | P00918 | 8/20 | 0.36 |
| ▸ | CA9 | Q16790 | 7/20 | 0.36 |
| ▸ | CA12 | O43570 | 3/20 | 0.36 |
| ▸ | CA7 | P43166 | 3/20 | 0.36 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 0.36 |
| ▸ | CA3 | P07451 | 2/20 | 0.36 |
| ▸ | CA4 | P22748 | 2/20 | 0.36 |
| ▸ | CA6 | P23280 | 2/20 | 0.36 |
| ▸ | CA5A | P35218 | 2/20 | 0.36 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.36 |
| ▸ | RECQL | P46063 | 2/20 | 0.35 |
| ▸ | TSHR | P16473 | 2/20 | 0.35 |
| ▸ | CES2 | O00748 | 1/20 | 0.35 |
| ▸ | GLA | P06280 | 1/20 | 0.35 |
| ▸ | HPGD | P15428 | 1/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.35 |
| ▸ | BLM | P54132 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6263292 | 1.00 | DNM1 (0.39) | DNM1CA1CA2CA9CA12 | |
| SCHEMBL2301357 | 0.91 | LPAR2 (0.44) | — | |
| SCHEMBL935452 | 0.82 | ALDH1A1 (0.41) | — | |
| SCHEMBL12257499 | 0.78 | LPAR3 (0.41) | CA1CA2CA9CA12CA7 | |
| SCHEMBL12257497 | 0.78 | LPAR3 (0.41) | CA1CA2CA9CA12CA7 | |
| SCHEMBL11508110 | 0.76 | THRB (0.38) | CA1CA2CA9CA12CA7 | |
| SCHEMBL15554489 | 0.76 | THRB (0.38) | CA1CA2CA9CA12CA7 | |
| SCHEMBL6021113 | 0.74 | MEN1 (0.45) | TSHRCES2THRBMEN1HTT | |
| SCHEMBL14118722 | 0.74 | DNM1 (0.42) | DNM1CA1CA2CA9CA12 | |
| SCHEMBL1254027 | 0.74 | DNM1 (0.42) | DNM1CA1CA2CA9CA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110250641-A1 | ZWITTERIONIC ACID-LABILE SURFACTANTS AND METHODS OF USE | PROTEA BIOSCIENCES, INC. (A WEST VIRGINIA CORPORATION) | 2011-10-13 | — | — | US | disclosed |
| US-20110250641-A1 | ZWITTERIONIC ACID-LABILE SURFACTANTS AND METHODS OF USE | PROTEA BIOSCIENCES, INC. (A WEST VIRGINIA CORPORATION) | 2011-10-13 | — | — | US | disclosed |
| US-20110250641-A1 | ZWITTERIONIC ACID-LABILE SURFACTANTS AND METHODS OF USE | PROTEA BIOSCIENCES, INC. (A WEST VIRGINIA CORPORATION) | 2011-10-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110250641-A1 | ZWITTERIONIC ACID-LABILE SURFACTANTS AND METHODS OF USE | SGMS1, SGMS2, PHOSPHO1 | DNM1 325/4885CA1 187/4885CA2 150/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.